RepRisk data shows increase in greenwashing with one in three greenwashing public companies also linked to social washing
Research by RepRisk reveals one in every four climate-related ESG risks globally was linked to…
Month: October 2023
Fujitsu and Atmonia discover a novel catalyst candidate for clean ammonia synthesis leveraging high-speed quantum chemical calculations
TOKYO, Oct 3, 2023 – (JCN Newswire) – TOKYO, Oct 3, 2023 – (JCN Newswire)…
CJPT strengthens efforts in Japan and Thailand to achieve carbon neutrality and solve logistics issues
Toyota City, Japan, Oct 2, 2023 – (JCN Newswire) – Toyota City, Japan, Oct 2,…
Driving Action for Global Climate Change: Over 1000 global industry leaders to convene in Dubai at upcoming Future Sustainability Forum hosted by DIFC
DUBAI, Oct 3, 2023 – (ACN Newswire) – Dubai is set to take centre stage…
Arvig Enrolls in Enhanced ACAM, Commits to 100Mb Speed Target for Rural Areas
PERHAM, Minn., Oct. 02, 2023 (GLOBE NEWSWIRE) — Arvig has elected to enroll in a…
DigitalBridge to Participate in Upcoming Investor and Industry Conferences in October 2023
BOCA RATON, Fla.–(BUSINESS WIRE)–#digitalbridge—DigitalBridge Group, Inc. (“DigitalBridge” or the “Company”) (NYSE: DBRG), a leading global…
NW Natural Water Expands Arizona Presence with Acquisition in Major Phoenix Suburb
PORTLAND, Ore.–(BUSINESS WIRE)–NW Natural Water Company, LLC (NW Natural Water), a wholly-owned subsidiary of Northwest…
Tenaya Therapeutics Publishes Preclinical Data in Circulation Highlighting the Clinical Potential of Cellular Reprogramming for Cardiac Regeneration
Novel AAV-Based Approach Regenerated Myocardial Cells and Demonstrated Durable Benefit to Heart Function in Rodent…
TFF Pharmaceuticals Congratulates our Scientific Advisory Board Member, Drew Weissman, M.D., Ph.D., for Receiving the Nobel Prize in Physiology or Medicine for his Pioneering Work Enabling the Development of mRNA COVID-19 Vaccines
FORT WORTH, Texas, Oct. 02, 2023 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage…
Immunovant Announces Closing of Upsized Common Stock Financing and Full Exercise of Underwriters’ Option to Purchase Additional Shares
NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology…
Driven By Global Momentum, PubMatic Brings Activate to APAC
Dentsu APAC, iQIYI, KINESSO India, Madison Digital, and Wishmedia are Among the Asia-Pacific Launch Partners…
Driven By Global Momentum, PubMatic Brings Activate to APAC
Dentsu APAC, iQIYI, KINESSO India, Madison Digital, and Wishmedia are Among the Asia-Pacific Launch Partners…
Mauve Selects USDC and EURC as Exclusive Stablecoins on Newly Launched Platform
Georgetown, Cayman Islands–(Newsfile Corp. – October 2, 2023) – Mauve, the first fully compliant non-custodial…
American Aires Announces Convertible Debenture Conversions
Toronto, Ontario–(Newsfile Corp. – October 2, 2023) – American Aires Inc. (CSE: WIFI) (OTC Pink:…
Wedbush Securities Initiates Coverage of the U.S. REIT Industry and Welcomes Richard Anderson as Managing Director, Equity Research, and Jay Kornreich as Vice President, Equity Research
LOS ANGELES–(BUSINESS WIRE)–Wedbush Securities, one of the nation’s leading independent diversified financial services providers, is…
KBRA Assigns Preliminary Ratings to Mariner Finance Issuance Trust 2023-A
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to five classes of notes issued from Mariner Finance…
Spruce Power Announces Reverse Stock Split
1-for-8 reverse stock split of Spruce’s common stock approved by stockholders Spruce’s common stock anticipated…
TheLoops Sets New CX Productivity Standards With GenAI Features For It’s Predictive Data Platform
See the new features in action in a virtual fireside chat on October 4th, 2023…
Praxis Precision Medicines Provides Portfolio Update at 2023 R&D Day
Positive results from preliminary analysis of PRAX-222 Part 1 showed 44% median reduction in seizures…
Checkpoint Therapeutics Announces Exercise of Warrants for $11.13 Million in Gross Proceeds
WALTHAM, Mass., Oct. 02, 2023 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a…